Oncocyte Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update

March 10, 2022

Biotechnology

Hoth Therapeutics to Attend Sequire Investor Summit January 21-23, 2025

January 17, 2025
ImmunoPrecise Antibodies Realigns Pipeline Strategy, Empowering Drug Discovery with AI and First-Principles Innovation

January 17, 2025
HyBryte™ Expanded Treatment Continues to Demonstrate Positive Outcomes in Early-Stage Cutaneous T-Cell Lymphoma

January 14, 2025
Aditxt’s Board of Directors Unanimously Approve Positioning Pearsanta for IPO to Support Global Launch of its Early Cancer Detection Platform

January 13, 2025